IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Serotonin-Norepinephrine Reuptake Inhibitors

Drug Profile, Volume 02 Issue 3 – July to September 2009

Authors

Dr. Jayakrishnan A V, D. Ortho, M.S. Ortho, MCh (Neuro), Consultant Neuro & Spine Surgeon, EMS Co Operative Hospital & Research Centre, Perinthalmanna; Secretary, Kerala Medical Journal.


Abstract

Serotonin-Norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant used in the treatment of major depression and other mood disorders. SNRIs were developed more recently than SSRIs, and there are relatively few of them. Their efficacy as well as their tolerability appears to be somewhat better than the SSRIs’. Abrupt discontinuation of SNRI- medication usually leads to a discontinuation syndrome which could include states of anxiety and further symptoms. The most common side effects include nausea, drowsiness, headache, changes in appetite, vivid dreams etc.

Keywords: Antidepressants, SNRI, Clinical uses


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician